![Cécile Thébault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cécile Thébault
Directeur/Membre du Conseil chez
Invers SA
Profil
Cécile Thébault is an Investment Director at Sofimac Régions SAS since 2010.
She is also a Member-Supervisory Board at Invers SA since 2019.
Previously, she held positions as a Director at Imaxio SA, ImmunID SAS, Biom'Up SA, Afyren SAS, and Theranexus SA. Ms. Thébault completed her undergraduate degree at Ecole Supérieure de Commerce de Clermont-Ferrand.
Postes actifs de Cécile Thébault
| Sociétés | Poste | Début |
|---|---|---|
Sofimac Régions SAS
 Sofimac Régions SAS Investment ManagersFinance Sofimac Régions is an active manager which specializes in making equity investments in unlisted small businesses mainly based in the Auvergne, Rhône-Alpes, Limousin, and Provence-Alpes-Côte d'Azur regions in France. The firm invests in businesses in the technology and industrial sectors at all stages of development, from seed capital to buyouts. Sofimac Régions seeks to identify companies with good growth and valuation potential and carries out campaigns to identify potential investee companies. The firm analyzes potential investee company management, products, markets and strategy, as well as their historical and forecast financial statements and financing needs. The firm monitors investments through regular contacts with company management, assisting them with their strategic thinking. Their exit may be the sale of the company, a secondary buyout or an IPO. Sofimac Régions seeks to set up new innovative, high technology companies based on scientific, technological and marketing criteria as well as the founder's ability to successfully implement his corporate plan. The firm may co-invest alongside other seed or early-stage venture capital funds, investing within a framework of organizations that support innovation. They fund the costs of building a prototype and invest additional funds to mass produce and market the product if successful at the end of the seed stage. They evaluate start-up and early-stage projects in terms of technology, intellectual property rights, products and markets, choosing business plans based on the company's management capabilities and the potential to market their technology and products internationally. Sofimac Régions participates in investee company development through organic growth, acquisitions and ownership transfers in the manufacturing and services sectors, investing in companies with high growth potential. The firm coordinates financial engineering and maintains close relations with the investee company's management, providing financing over the medium-term with the aim of exiting after five to seven years. | Membre du Comité d'Investissement | 22/06/2010 |
Invers SA
 Invers SA Agricultural Commodities/MillingProcess Industries Engages in breeding of insects as a protein substitute for animal feed | Directeur/Membre du Conseil | 28/06/2019 |
Anciens postes connus de Cécile Thébault
| Sociétés | Poste | Fin |
|---|---|---|
| AFYREN | Directeur/Membre du Conseil | - |
| BIOM'UP | Directeur/Membre du Conseil | - |
ImmunID SAS
 ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Directeur/Membre du Conseil | - |
| THX PHARMA | Directeur/Membre du Conseil | - |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Cécile Thébault
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Ecole Supérieure de Commerce de Clermont-Ferrand
 Ecole Supérieure de Commerce de Clermont-Ferrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions is an active manager which specializes in making equity investments in unlisted small businesses mainly based in the Auvergne, Rhône-Alpes, Limousin, and Provence-Alpes-Côte d'Azur regions in France. The firm invests in businesses in the technology and industrial sectors at all stages of development, from seed capital to buyouts. Sofimac Régions seeks to identify companies with good growth and valuation potential and carries out campaigns to identify potential investee companies. The firm analyzes potential investee company management, products, markets and strategy, as well as their historical and forecast financial statements and financing needs. The firm monitors investments through regular contacts with company management, assisting them with their strategic thinking. Their exit may be the sale of the company, a secondary buyout or an IPO. Sofimac Régions seeks to set up new innovative, high technology companies based on scientific, technological and marketing criteria as well as the founder's ability to successfully implement his corporate plan. The firm may co-invest alongside other seed or early-stage venture capital funds, investing within a framework of organizations that support innovation. They fund the costs of building a prototype and invest additional funds to mass produce and market the product if successful at the end of the seed stage. They evaluate start-up and early-stage projects in terms of technology, intellectual property rights, products and markets, choosing business plans based on the company's management capabilities and the potential to market their technology and products internationally. Sofimac Régions participates in investee company development through organic growth, acquisitions and ownership transfers in the manufacturing and services sectors, investing in companies with high growth potential. The firm coordinates financial engineering and maintains close relations with the investee company's management, providing financing over the medium-term with the aim of exiting after five to seven years. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Health Technology |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Health Technology |
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Theranexus SA
 Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases | Health Technology |
Afyren SAS
 Afyren SAS BiotechnologyHealth Technology Operates as a biotechnology company which produces organic and carboxylic acids | Health Technology |
Invers SA
Invers SA Agricultural Commodities/MillingProcess Industries Engages in breeding of insects as a protein substitute for animal feed | Process Industries |
